153 related articles for article (PubMed ID: 37019909)
1. Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection.
Pieren DKJ; Kuguel SG; Rosado J; Robles AG; Rey-Cano J; Mancebo C; Esperalba J; Falcó V; Buzón MJ; Genescà M
Nat Commun; 2023 Apr; 14(1):1887. PubMed ID: 37019909
[TBL] [Abstract][Full Text] [Related]
2. Peripheral and lung resident memory T cell responses against SARS-CoV-2.
Grau-Expósito J; Sánchez-Gaona N; Massana N; Suppi M; Astorga-Gamaza A; Perea D; Rosado J; Falcó A; Kirkegaard C; Torrella A; Planas B; Navarro J; Suanzes P; Álvarez-Sierra D; Ayora A; Sansano I; Esperalba J; Andrés C; Antón A; Ramón Y Cajal S; Almirante B; Pujol-Borrell R; Falcó V; Burgos J; Buzón MJ; Genescà M
Nat Commun; 2021 May; 12(1):3010. PubMed ID: 34021148
[TBL] [Abstract][Full Text] [Related]
3. Lung tissue-resident memory T cells: the gatekeeper to respiratory viral (re)-infection.
Tang J; Sun J
Curr Opin Immunol; 2023 Feb; 80():102278. PubMed ID: 36565508
[TBL] [Abstract][Full Text] [Related]
4. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
Quinti I; Locatelli F; Carsetti R
Front Immunol; 2021; 12():815404. PubMed ID: 35126372
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary resident memory T cells in respiratory virus infection and their inspiration on therapeutic strategies.
Zhang M; Li N; He Y; Shi T; Jie Z
Front Immunol; 2022; 13():943331. PubMed ID: 36032142
[TBL] [Abstract][Full Text] [Related]
6. Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.
Mitsi E; Diniz MO; Reiné J; Collins AM; Robinson RE; Hyder-Wright A; Farrar M; Liatsikos K; Hamilton J; Onyema O; Urban BC; Solórzano C; Belij-Rammerstorfer S; Sheehan E; Lambe T; Draper SJ; Weiskopf D; Sette A; Maini MK; Ferreira DM
Nat Commun; 2023 Oct; 14(1):6815. PubMed ID: 37884506
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.
Jung JH; Rha MS; Sa M; Choi HK; Jeon JH; Seok H; Park DW; Park SH; Jeong HW; Choi WS; Shin EC
Nat Commun; 2021 Jun; 12(1):4043. PubMed ID: 34193870
[TBL] [Abstract][Full Text] [Related]
8. Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination.
Barateau V; Peyrot L; Saade C; Pozzetto B; Brengel-Pesce K; Elsensohn MH; Allatif O; Guibert N; Compagnon C; Mariano N; Chaix J; Djebali S; Fassier JB; Lina B; Lefsihane K; Espi M; Thaunat O; Marvel J; Rosa-Calatrava M; Pizzorno A; Maucort-Boulch D; Henaff L; Saadatian-Elahi M; Vanhems P; Paul S; Walzer T; Trouillet-Assant S; Defrance T
Sci Transl Med; 2023 Mar; 15(687):eade0550. PubMed ID: 36921035
[TBL] [Abstract][Full Text] [Related]
9. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
Front Immunol; 2021; 12():726960. PubMed ID: 34671348
[TBL] [Abstract][Full Text] [Related]
10. SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype.
Silvestri Y; Clemente F; Moschetti G; Maioli S; Carelli E; Espadas de Arias A; Torelli R; Longhi E; De Feo T; Crosti M; Sarnicola ML; Salvi M; Mantovani G; Arosio M; Bombaci M; Pesce E; Grifantini R; Abrignani S; Geginat J; Muller I
Clin Immunol; 2023 Sep; 254():109684. PubMed ID: 37451415
[TBL] [Abstract][Full Text] [Related]
11. Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination.
Liang B; Xiang T; Wang H; Li Z; Quan X; Feng X; Li S; Lu S; Fan L; Xu L; Wang T; Wang X; Zhu B; Wang J; Yang D; Liu J; Zheng X
Front Immunol; 2022; 13():966098. PubMed ID: 35979361
[TBL] [Abstract][Full Text] [Related]
12. Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination.
Casado JL; Vizcarra P; Martín-Hondarza A; Blasco M; Grandal-Platero M; Haemmerle J; Fernández-Escribano M; Vallejo A
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992336
[TBL] [Abstract][Full Text] [Related]
13. Local SARS-CoV-2 Peptide-Specific Immune Responses in Lungs of Convalescent and Uninfected Human Subjects.
Goliwas KF; Wood AM; Simmons CS; Khan R; Khan SA; Wang Y; Berry JL; Athar M; Mobley JA; Kim YI; Thannickal VJ; Harrod KS; Donahue JM; Deshane JS
medRxiv; 2022 Jan; ():. PubMed ID: 34518842
[TBL] [Abstract][Full Text] [Related]
14. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
[TBL] [Abstract][Full Text] [Related]
15. Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
Pušnik J; König J; Mai K; Richter E; Zorn J; Proksch H; Schulte B; Alter G; Streeck H
J Virol; 2022 Aug; 96(15):e0076022. PubMed ID: 35862718
[TBL] [Abstract][Full Text] [Related]
16. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2.
Stewart EL; Counoupas C; Johansen MD; Nguyen DH; Miemczyk S; Hansbro NG; Ferrell KC; Ashhurst A; Alca S; Ashley C; Steain M; Britton WJ; Hansbro PM; Petrovsky N; Triccas JA
Mucosal Immunol; 2022 Jun; 15(6):1405-1415. PubMed ID: 36411332
[TBL] [Abstract][Full Text] [Related]
18. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
[TBL] [Abstract][Full Text] [Related]
19. Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
Sedegah M; Porter C; Goguet E; Ganeshan H; Belmonte M; Huang J; Belmonte A; Inoue S; Acheampong N; Malloy AMW; Hollis-Perry M; Jackson-Thompson B; Ramsey KF; Alcorta Y; Maiolatesi SE; Wang G; Reyes AE; Illinik L; Sanchez-Edwards M; Burgess TH; Broder CC; Laing ED; Pollett SD; Villasante E; Mitre E; Hollingdale MR
PLoS One; 2022; 17(10):e0276241. PubMed ID: 36251675
[TBL] [Abstract][Full Text] [Related]
20. A ubiquitous bone marrow reservoir of preexisting SARS-CoV-2-reactive memory CD4
Li J; Reinke S; Shen Y; Schollmeyer L; Liu YC; Wang Z; Hardt S; Hipfl C; Hoffmann U; Frischbutter S; Chang HD; Alexander T; Perka C; Radbruch H; Qin Z; Radbruch A; Dong J
Front Immunol; 2022; 13():1004656. PubMed ID: 36268016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
